Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM    DSM   NL0000009827

ROYAL DSM (DSM)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Royal DSM : DSM hosts successful 2017 Innovation Partnering Conference with eight promising food & biotech start-ups in Delft

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/06/2017 | 10:10am CET

Speaking at the opening of the conference, Patrick Niels, President of DSM Food Specialties, emphasized the importance of venturing and open innovation in the modern business world: 'At DSM Food Specialties, we aim to enable better food for everyone, helping to make people's diets healthier, tastier, and more sustainable. Encouraging open innovation like this is an important part of our approach; there are so many great ideas and courageous start-ups out there, and this is one way for us to tap into them, hopefully to the benefit of our customers, our business - and of course for the entrepreneurs themselves.'

Eight finalists

An expert panel from DSM and Nutrition Capital Network evaluated a long-list of entrepreneurs and innovators who applied to attend Connecting Bright Innovations 2017, ultimately inviting eight companies to pitch in Delft.

The finalists were: 3f Bio (UK), Alderys (France), Biosyntia (Denmark), Chinova Bioworks (Canada), Kiverdi (US), Pectcof (Netherlands), Swiss DeCode (Switzerland) and Zymtronix (US).

High standard

Krijn Rietveld, Senior Vice President Partnering for Innovation at DSM, heads the Connecting Bright Innovations 2017 panel: 'We were impressed by the high standard of the pitches we heard during the conference, so congratulations to all who took part. It's inspiring to see such passion, drive and energy. The technologies and business cases on show were very interesting, and I am sure that there are a number with whom we will be able to take our relationship further, to see how DSM can help scale up their promising platforms to realize their full commercial potential.'

Delft, world-leading location for biotech

Connecting Bright Innovations 2017 was held at the Rosalind Franklin Biotechnology Center on the DSM site in Delft. The center's location at the heart of the Biotech Campus Delft allows DSM to rapidly develop and scale up biotechnology solutions for promising new ingredients for customer validation and commercial roll-out. The Biotech Campus Delft, an initiative of DSM Delft, Delft University of Technology, the City of Delft and the Province of South Holland, builds on the location's existing competences and internationally recognized position as a world leader in biotechnology development. It brings together fundamental science and R&D, applications expertise, piloting and scale-up facilities as well commercial and market insights and relationships on one location, being also the global headquarters of DSM Food Specialties.

Koninklijke DSM NV published this content on 06 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 06 October 2017 08:09:04 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ROYAL DSM
12/11 AKZONOBEL : DSM - Rocky Mountain Institute case study showcases successful aggre..
12/11 ROYAL DSM : DSM as part of a broad coalition of major global companies calls for..
12/11 ROYAL DSM : DSM announces Akulon® and Novamid® polyamide 6 price increase
12/07 AKZONOBEL : RMI Case Study Showcases Successful Aggregation Of Corporate Renewab..
11/30 ROYAL DSM : DSM’s new hydrolysis-resistant Arnite® PBT provides new cost-e..
11/29 ROYAL DSM : DSM wins Food Ingredients Innovation Award with Delvo®Cheese CT-Ligh..
11/27 ROYAL DSM : DSM to expand capacity of high performance plastics
11/27 ROYAL DSM : DSM introduces new culture for more efficient production of tasty, f..
11/27 AMYRIS, INC. (NASDAQ : AMRS) Files An 8-K Entry into a Material Definitive Agree..
11/24 ROYAL DSM : DSM presents natural taste modulator at FiE 2017
More news
News from SeekingAlpha
12/10 Amyris Solves Cash Woes With DSM Deal, On Track For 2019 Profitability
11/05 Koninklijke DSM NV 2017 Q3 - Results - Earnings Call Slides
11/04 Royal DSM (RDSMY) Q3 2017 Results - Earnings Call Transcript
11/04 Royal DSM NV ADR 2017 Q3 - Results - Earnings Call Slides
10/17 Why I Bought Corbion In Order To Continue Investing In The Technology Of Terr..
Financials (€)
Sales 2017 8 505 M
EBIT 2017 921 M
Net income 2017 1 313 M
Debt 2017 865 M
Yield 2017 2,31%
P/E ratio 2017 10,48
P/E ratio 2018 20,18
EV / Sales 2017 1,83x
EV / Sales 2018 1,77x
Capitalization 14 666 M
Chart ROYAL DSM
Duration : Period :
Royal DSM Technical Analysis Chart | DSM | NL0000009827 | 4-Traders
Technical analysis trends ROYAL DSM
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 82,7 €
Spread / Average Target 2,3%
EPS Revisions
Managers
NameTitle
Feike Sijbesma CEO & Chairman-Management Board
Robert John Routs Chairman-Supervisory Board
Géraldine Matchett Chief Financial Officer & Member-Management Board
Robert M. van Leen Head-Innovation, Research & Development
Tom de Swaan Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM39.64%17 340
BASF6.28%102 241
EVONIK INDUSTRIES12.74%17 383
GROUPE BRUXELLES LAMBERT13.84%17 347
MITSUBISHI CHEMICAL HOLDINGS CORP.58.69%16 095
FMC CORP57.02%12 179